Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome
Authors
Keywords
-
Journal
JAMA Oncology
Volume 7, Issue 2, Pages 230
Publisher
American Medical Association (AMA)
Online
2020-10-31
DOI
10.1001/jamaoncol.2020.6252
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
- (2020) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
- (2019) Piper Nicolosi et al. JAMA Oncology
- The Missing Diversity in Human Genetic Studies
- (2019) Giorgio Sirugo et al. CELL
- Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
- (2019) James L. Mohler et al. Journal of the National Comprehensive Cancer Network
- Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines
- (2019) Cynthia L. Neben et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Hereditary Cancer Syndromes—A Primer on Diagnosis and Management, Part 2: Gastrointestinal Cancer Syndromes
- (2019) N. Jewel Samadder et al. MAYO CLINIC PROCEEDINGS
- Hereditary Cancer Syndromes—A Primer on Diagnosis and Management
- (2019) N. Jewel Samadder et al. MAYO CLINIC PROCEEDINGS
- Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European
- (2019) Mesaki K. Ndugga-Kabuye et al. Familial Cancer
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019
- (2019) Samir Gupta et al. Journal of the National Comprehensive Cancer Network
- Impact of free cancer predisposition cascade genetic testing on uptake in Singapore
- (2019) Eliza Courtney et al. npj Genomic Medicine
- Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention
- (2019) Natalie E. Griffin et al. GYNECOLOGIC ONCOLOGY
- When Should Patients Undergo Genetic Testing for Hereditary Colon Cancer Syndromes?
- (2018) Gregory Idos et al. Clinical Gastroenterology and Hepatology
- Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature
- (2018) Megan C. Roberts et al. HEALTH AFFAIRS
- Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
- (2018) Maeve A Lowery et al. JNCI-Journal of the National Cancer Institute
- Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
- (2018) Maeve A Lowery et al. JNCI-Journal of the National Cancer Institute
- Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma
- (2018) Maria I. Carlo et al. JAMA Oncology
- Prospective Study of Germline Genetic Testing in Incident Cases of Pancreatic Adenocarcinoma
- (2018) Randall Brand et al. CANCER
- Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative
- (2018) Jennifer L Caswell-Jin et al. JNCI-Journal of the National Cancer Institute
- Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
- (2018) Peter D. Beitsch et al. JOURNAL OF CLINICAL ONCOLOGY
- Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk
- (2017) Jennifer L Caswell-Jin et al. GENETICS IN MEDICINE
- Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing
- (2017) Joshua W. Knowles et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing
- (2017) Diana Mandelker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach
- (2017) Goli Samimi et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer
- (2017) Matthew B. Yurgelun et al. JOURNAL OF CLINICAL ONCOLOGY
- Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer
- (2017) Allison W. Kurian et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017
- (2017) Samir Gupta et al. Journal of the National Comprehensive Cancer Network
- A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer
- (2017) Anthony Eccleston et al. VALUE IN HEALTH
- Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories
- (2017) Eric T. Rosenthal et al. Cancer Genetics
- Second Opinions From Medical Oncologists for Early-Stage Breast Cancer
- (2017) Allison W. Kurian et al. JAMA Oncology
- Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer
- (2016) Nadine Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
- (2016) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- Prostate Cancer, Version 1.2016
- (2016) James L. Mohler et al. Journal of the National Comprehensive Cancer Network
- Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort
- (2016) Charité Ricker et al. Cancer Genetics
- Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
- (2015) Andrea Desmond et al. JAMA Oncology
- A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment
- (2014) Heather Hampel et al. GENETICS IN MEDICINE
- Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
- (2014) Allison W. Kurian et al. JOURNAL OF CLINICAL ONCOLOGY
- A Statewide Survey of Practitioners to Assess Knowledge and Clinical Practices Regarding Hereditary Breast and Ovarian Cancer
- (2013) Tuya Pal et al. Genetic Testing and Molecular Biomarkers
- The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
- (2010) Mercy Mvundura et al. GENETICS IN MEDICINE
- Sharing Genetic Test Results in Lynch Syndrome: Communication With Close and Distant Relatives
- (2008) Elena M. Stoffel et al. Clinical Gastroenterology and Hepatology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started